Regulus Therapeutics Q4 Operating Expenses USD 13.746 Million

Reuters
03-14
March 13 (Reuters) - Regulus Therapeutics Inc ::
*REGULUS THERAPEUTICS Q4 OPERATING EXPENSES USD 13.746 MILLION
*REGULUS THERAPEUTICS Q4 INCOME FROM OPERATIONS USD -13.746 MILLION
*REGULUS THERAPEUTICS Q4 BASIC EPS USD -0.2
*REGULUS THERAPEUTICS Q4 PRETAX PROFIT USD -12.791 MILLION
*REGULUS THERAPEUTICS Q4 NET INCOME USD -12.791 MILLION
*REGULUS THERAPEUTICS: CO EXPECTS ITS CASH RUNWAY TO EXTEND INTO EARLY 2026

((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 13-MAR-202520:05:03.45 GMT

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10